SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
711GS: Gilead Sciences Inc. EPS (FY Dec) 2004E $0.85, 2005E $1.08 Outperform/Neutramopgcw-9/14/2004
710>>FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug. 26, 2004-- Gilead Sciences (Ntuck-8/26/2004
709GILD short interest just announced rose an astonishing 5.6 million over previousMaven1-8/25/2004
708WSJ - Key AIDS Study In Cambodia Now in Jeopardy [Viread] #reply-20403384Doc Bones-8/12/2004
707>>FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug. 2, 2004-- Gilead Sciences (Natuck-8/2/2004
706Leg: * Yesterday, Gilead reported 2Q04 EPS of $0.49, significantly above both oumopgcw-8/2/2004
705Gilead beats by a ways. Didn't know they had an interest in Eyetech. Appartuck-7/29/2004
704From Leg: We are raising our 2Q04 estimate from $0.34 to $0.37 and our FY2004 Emopgcw-7/28/2004
703Activists demand Gilead halt AIDS tests involving prostitutes SAN FRANCISCO (APSam Citron-7/14/2004
702As Bird Flu Persists, Global Leaders Prepare for the Worst [NYT] #reply-2029893Doc Bones-7/10/2004
701Gilead Pharmaceuticals (GILD-NNM) by First Global (60.12, April 23) The launch omopgcw-5/3/2004
700GS: GILD (OP/N): Strong Q1, raising rating and estimates 52-Week Range US$70-44mopgcw-4/26/2004
699Gilead 4th-quarter earnings rise, shares fall <i> GILD at 55, 9:20 am FriDoc Bones-1/30/2004
698Hi, I was wondering if Tamiflu is being distributed by Gilead or is it with Roctoccodolce-1/28/2004
697Gilead Sciences Inc. EPS (FY Dec) 2003E $1.45, 2004E $1.70 In-Line/Neutral (GILDmopgcw-11/27/2003
696Gilead Sciences Calls for Redemption of Convertible 2003-11-20 16:30 (New York) mopgcw-11/20/2003
695Forbes: The Golden Age of Antiviral Drugs Kerry A. Dolan and Zina Moukheiber, mopgcw-10/27/2003
694GS Note: Gilead Sciences Inc. EPS (FY Dec) 2003E $1.46, 2004E $1.82 In-Line/Neutmopgcw-10/23/2003
693GS Note: Gilead Sciences Inc. EPS (FY Dec) 2003E $1.46, 2004E $1.82 In-Line/Neumopgcw-10/15/2003
692GS Note: Gilead Sciences Inc. EPS (FY Dec) 2003E US$1.46, 2004E US$1.82 In-Line/mopgcw-9/29/2003
691Funny. Merrill reiterates buy or whatever. But only time i see them close to t10K a day-9/16/2003
690Chimerix Announces Licensing Deal With Gilead Sciences Friday September 12, 7:31michael_f_murphy-9/12/2003
689From GS: Analyst Comment Stock rating: In-Line Coverage view: Neutral Large-Capmopgcw-6/13/2003
688From Briefing.com >>11:56AM Gilead Sciences sells off on Viread concerns tuck-2/13/2003
687Looks like GILD is on the right track~ biz.yahoo.com joarel~joarel-12/8/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News